Does substance P trigger migraine attacks without aura?
Part of Brain & nervous system, Pain clinical trials.
This study tests whether a substance called substance P can cause migraine attacks in people who have migraine without aura. Results may help understand new ways to prevent or treat migraine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You weigh between 110 and 220 pounds (50 to 100 kg).
- You have been diagnosed with migraine without aura for at least 12 months.
- You have had 1 to 5 migraine days per month (on average) over the last 3 months.
- You do not have other major health problems like heart, lung, or brain injury conditions.
- You can avoid taking any medications (except birth control) and avoid headaches or migraines for a specific time before the study infusion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This study looks at blood samples from people with migraine to find proteins and other markers that might explain why migraines happen. The goal is to better understand migraine, which could help find better treatments in the future.
This study looks at how psilocybin affects the brain in people with migraines and in healthy volunteers. The goal is to understand why it may help with headache disorders.
This trial tests whether an oral capsule called butylphthalide (also known as NBP) can help prevent migraine attacks in adults who get them regularly. If you have migraines 4–14 days per month, this study may offer a new preventive option.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.